Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Marker Therapeutics (NASDAQ:MRKR) shares increased by 54.3% to $0.51 during Friday's regular session. The current volume of 63.7 million shares is 16959.7% of Marker Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $42.5 million.
  • Athenex (NASDAQ:ATNX) stock moved upwards by 50.75% to $0.95. As of 13:30 EST, this security is trading at a volume of 11.1 million shares, making up 997.5% of its average full-day volume over the last 100 days. The company's market cap stands at $115.4 million.
  • Progyny (NASDAQ:PGNY) shares rose 40.24% to $41.75. Progyny's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 297.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 billion. As per the press release, Q2 earnings came out yesterday.
  • Global Blood Therapeutics (NASDAQ:GBT) shares rose 36.77% to $65.64. As of 13:30 EST, this security is trading at a volume of 9.1 million shares, making up 553.1% of its average full-day volume over the last 100 days. The company's market cap stands at $4.2 billion.
  • GH Research (NASDAQ:GHRS) shares rose 27.28% to $15.49. The market value of their outstanding shares is at $805.8 million.
  • Selecta Biosciences (NASDAQ:SELB) stock moved upwards by 27.12% to $2.39. As of 13:30 EST, this security is trading at a volume of 5.1 million shares, making up 227.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $362.8 million. As per the press release, Q2 earnings came out yesterday.

Losers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock fell 58.0% to $5.91 during Friday's regular session. Trading volume for Quoin Pharmaceuticals's stock is 11.5 million as of 13:30 EST. This is 362.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
  • Health Catalyst (NASDAQ:HCAT) shares decreased by 36.29% to $11.64. Health Catalyst's stock is trading at a volume of 5.3 million shares as of 13:30 EST. This is 546.2% of its average full-day volume over the last 100 days. The company's market cap stands at $630.7 million. The company's, Q2 earnings came out yesterday.
  • Exagen (NASDAQ:XGN) stock declined by 22.72% to $6.42. Exagen's stock is trading at a volume of 60.7K shares as of 13:30 EST. This is 105.1% of its average full-day volume over the last 100 days. The company's market cap stands at $104.2 million. As per the news, the Q2 earnings report came out yesterday.
  • Heart Test Laboratories (NASDAQ:HSCS) shares decreased by 18.31% to $2.21. Trading volume for this security as of 13:30 EST is 712.3K, which is 61.4% of its average full-day volume over the last 100 days.
  • Cognition Therapeutics (NASDAQ:CGTX) stock declined by 15.56% to $3.04. As of 13:30 EST, Cognition Therapeutics's stock is trading at a volume of 1.7 million, which is 462.3% of its average full-day volume over the last 100 days. The company's market cap stands at $68.6 million.
  • Definitive Healthcare (NASDAQ:DH) stock fell 15.28% to $24.85. Trading volume for this security as of 13:30 EST is 1.3 million, which is 225.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.